TickerFactsScreenerDevelopers

KYNTRA BIO, INC. (KYNB) — Revenue

Annual figures by fiscal year, from SEC filings.

2013: $102.17M2014: $137.60M2015: $180.83M2016: $183.19M2017: $131.00M2018: $212.96M2019: $256.58M2020: $176.32M2021: $235.31M2022: $140.73M2023: $46.80M2024: $29.62M2025: $6.44M$6.44M
2013Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$6.44M-78.3%
2024$29.62M-36.7%
2023$46.80M-66.7%
2022$140.73M-40.2%
2021$235.31M+33.5%
2020$176.32M-31.3%
2019$256.58M+20.5%
2018$212.96M+62.6%
2017$131.00M-28.5%
2016$183.19M+1.3%
2015$180.83M+31.4%
2014$137.60M+34.7%
2013$102.17M—